PUBLICACIONES GEEIC - Área de Salud de Cáceres

Transcripción

PUBLICACIONES GEEIC:
N=166
1.
Molina-Infante
J,
Hirano
I.
Invited
editorial:
expanding
a
narrowperspectiveonnarrowcaliberesophagus
in
eosinophilicesophagitis.
AlimentPharmacolTher 2014, en prensa.
2.
Lucendo AJ, Sanchez-Cazalilla M, Molina-Infante J, Perez-Martinez I, Tenias JM,
Barrio J, et al. Transcultural adaptation and validation of the “Adult Eosinophilic
Esophagitis Quality of Life Questionnaire” into Spanish. Rev Esp Enf Dig
2014;106:386-94.
3.
Lucendo AJ, Arias A, Tenías JM, Rodriguez-Sanchez J, Gomez-Torrijos E, FeoBrito F, Molina-Infante J. Serum IgE-targeted elimination diets for treating
eosinophilic esophagitis: things are not what they seem. Allergy 2014;69:1567-9.
4.
Gisbert JP, Barrio J, Modolell I, Molina-Infante J, Aisa AP, Castro-Fernández M,
Rodrigo L, Cosme A, Gisbert JL, Fernández-Bermejo M, Marcos S, Marín AC,
McNicholl AG. Helicobacter Pylori First-Line and Rescue Treatments in the
Presence of Penicillin Allergy. Dig Dis Sci. 2014 Sep 19.
5.
Molina-Infante J, Arias A, Barrio J, Rodríguez-Sánchez J, Sanchez-Cazalilla M,
Lucendo AJ. Four-food group elimination diet for adult eosinophilic esophagitis: a
prospective multicenter study. J Allergy ClinImmunol. 2014 Aug 27.
6.
Molina-Infante J, Javier P. Gisbert. Optimizing clarithromycin-containing therapy
for Helicobacter pylori in the era of antibiotic resistance. World J Gastroenterol
2014;10:10338-47.
7.
Molina Infante J, Gisbert JP. Bismuth quadruple therapy with Pylera® for H. pylori
infection. Aliment Pharmacol Ther 2014;40:735-6.
8.
Molina Infante J, Katzka DA. Protonpumpinhibitor-responsive esophageal
eosinophilia. Current Opin Gastroenterol 2014;30:428-33.
9.
Molina Infante J, Lucendo AJ. Eosinophilic esophagitis: a practical approach to
diagnosis and management. Expert Rev Gastroenterol Hepatol 2014;16:1-10.
10.
Rodríguez-Sánchez J, Gómez Torrijos E, López Viedma B, de la Santa Belda E,
Martín Dávila F, García Rodríguez C, Feo Brito F, Olmedo Camacho J, Reales
Figueroa P, Molina-Infante J. Efficacy of IgE-targeted vs empiric six-food
elimination diets for adult eosinophilic oesophagitis. Allergy 2014;69:936-42.
11.
Molina Infante J, Gisbert JP, Dellon ES. Distinguishing PPI-responsive esophageal
eosinophilia from eosinophilic esophagitis: still a long way to go. Aliment
Pharmacol Ther 2014;39:1248-9.
Concierto Complejo Hospitalario de Cáceres – Universidad de Extremadura 1 12.
Molina-Infante J, Santolaria S, Montoro M, Esteve M, Fernandez-Bañares F. Nonceliac gluten sensitivity: a critical review of evidence. Gastroenterol Hepatol
2014;37:362-71.
13.
Molina-Infante J, Arias A, Vara-Brenes D, Prados-Manzano R, Gonzalez-Cervera J,
Alvarado-Arenas M, Lucendo AJ. Propofol administration is safe in adult
eosinophilic esophagitis patients sensitized to egg, soy or peanut. Allergy 2014
14.
Molina Infante J, Calvet X, Gisbert JP. The irony of oral iron: not an underdog for
post-GI bleeding anaemia. Aliment PharmacolTher 2014; 39:550-1.
15.
Lucendo AJ, Molina-Infante J. Emerging therapeutic strategies for eosinophilic
esophagitis. Curr Opin Treat Gastroenterol 2014;12:1-17.
16.
Molina Infante J, Gisbert JP. PPI-responsive esophageal eosinophilia: from initial
scepticism to consistent prospective data. Aliment PharmacolTher 2014; 39:229-30.
17.
Gisbert JP, Perez-Aisa A, Rodrigo L, Molina-Infante J, Modolell I, Bermejo F,
Castro-Fernández M, Antón R, Sacristán B, Cosme A, Barrio J, Harb Y, GonzalezBarcenas M, Fernandez-Bermejo M, Algaba A, Marín AC, McNicholl AG; On
behalf of the H. pylori Study Group of the Spanish Gastroenterology
Association.Third-line rescue therapy with bismuth-containing quadruple regimen
after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori
infection. DigDisSci 2014; 59:383-9.
18.
McNicholl AG, Marin AC, Molina-Infante J, Castro M, Barrio J, Ducons J, Calvet
X, de la Coba C, Montoro M, Bory F, Perez-Aisa A, Forné M, Gisbert JP;
Participant Centres. Randomised clinical trial comparing sequential and concomitant
therapies for Helicobacter pylori eradication in routine clinical practice. Gut 2014;
63:244-9.
19.
Vara-Brenes D, Santiago-Cuñer A, Mateos-Rodríguez JM, Fernández-Bermejo M,
Molina-Infante J. Aeromonashydrophila colitis as the initial presentation of colon
cancer. GastroenterolHepatol 2014; 37:270-2.Molina-Infante J, Javier P. Gisbert.
20.
Molina Infante J, Gisbert JP. PPI-responsive esophageal eosinophilia: from initial
skepticism to consistent prospective data. AlimentPharmacolTher 2014; 39:229-30.
21.
Molina Infante J, Romano M, Gisbert JP. Reply. Gastroenterology 2013;145:14978.
22.
Molina Infante J, Gisbert JP. Probiotics for Helicobacter pylori infection: not ready
for prime time. Rev Esp Enf Dig 2013; 105:441-1.
Jesus M. Gonzalez-Santiago, Elisa Martin-Noguerol, Gema Vinagre-Rodriguez,
Moisés Hernandez-Alonso, Carmen Dueñas-Sadornil, Belen Perez-Gallardo, José
M. Mateos-Rodriguez, Miguel Fernandez-Bermejo, Pilar Robledo-Andres, Javier
Molina-Infante. Intermittent boluses versus pump continuous infusion for
endoscopist-directed propofol administration in colonoscopy. Rev Esp Enf Dig
2013;105:378-84.
24.
O´Connor JP, Molina-Infante J, Gisbert JP, O´Morain C. Treatment of Helicobacter
pylori infection 2013. Helicobacter 2013; Suppl 1:58-65.
25.
Molina Infante J, Gisbert JP. Overcoming antibiotic resistance with Helicobacter
pylori infection: optimization is the way forward. Aliment Pharmacol Ther 2013;
38(2):204-5.
26.
Molina Infante J, Katzka DA, Gisbert JP. Review article: proton pump inhibitor
therapy for suspected eosinophilic oesophagitis. Aliment Pharmacol Ther 2013;
37(12):1157-64.
27.
Molina Infante J, Gisbert JP. Seeking esophageal eosinophilia among unselected
patients: looking for a needle in a haystack?.Aliment Pharmacol Ther 2013;
37(10):1029-30.
28.
Javier Molina-Infante, Marco Romano, Miguel Fernandez-Bermejo, Alessandro
Federico, Antonietta G. Gravina, Liliana Pozzati, Elena Garcia-Abadia, Gema
Vinagre-Rodriguez, Carmen Martinez-Alcala, Moises Hernandez-Alonso, Agnese
Miranda, Maria RosariaIovene, Carmen Pazos-Pacheco, Javier P. Gisbert.
Optimized Non-Bismuth Quadruple Therapies Cure Most Patients with Helicobacter
pylori Infection in Populations with High Rates of Antibiotic Resistance.
Gastroenterology 2013; 145(1):121-128.e1.
29.
Molina Infante J, Gisbert JP. Quadruple therapy for Helicobacter pylori. Lancet
2013; 381(9876):1459.
30.
Vara-Brenes D, Prados-Manzano R, Molina-Infante J, Mateos-Rodríguez JM,
Fernández-Bermejo M. Chemical colitis due to hydrogenperoxide enema.
Gastroenterol Hepatol 2013; 36(6):439-40.
31.
Molina Infante J, Gisbert JP. Actualización de la eficacia de la terapia triple para la
infección por Helicobacter pylori y de la resistencia a claritromicina en España
(2007-2012). Gastroentero lHepatol 2013; 36(6):375-81..
32.
Gisbert JP, Bermejo F, Boixeda D, Bory F, Bujanda L, Castro-Fernández M,
Domínguez E, Elizalde JI, Forné M, Gené E, Gomollón F, Lanas A, Martín de
Argila C, McNicholl1 AG, Mearin F, Molina-Infante J, Montoro M, Pajares JM,
Pérez-Aisa A, Pérez-Trallero E, Sánchez J, Calvet X. III Conferencia Española de
Consenso sobre la infección por Helicobacter pylori. Gastroenterol Hepatol 2013;
36(5):340-74.
Gisbert JP, Molina Infante J, Marin A, Vinagre-Rodriguez G, Barrio J, McNicholl
A. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth
quadruple “sequential” or “concomitant” treatment to eradicate H. pylori infection.
Scand J Gastroenterol 2013; 48(6):652-6.
34.
Elisa Martín-Noguerol, Jesus M. González-Santiago, Carmen Martínez-Alcalá,
Gema Vinagre-Rodríguez, Moisés Hernández-Alonso, Carmen Dueñas-Sadornil,
Belén Pérez-Gallardo, José M. Mateos-Rodríguez, Miguel Fernández-Bermejo,
Javier Molina-Infante. Split-dose sodium picosulphate/magnesium citrate for
morning colonoscopies performed from 2 to 6 hours after fluids intake.
Gastroenterol Hepatol 2013; 36(4):254-60.
35.
Lucendo AJ, Arias A, Molina Infante J, et al. Diagnostic and therapeutic
management of eosinophilic oesophagitis in children and adults: results from a
spanish registry of clinical practice. Dig Liv Dis 2013; 45(7):562-8.
36.
Molina-Infante J, Katzka DA. Tissue biomarkers distinguishing GERD from EoE:
concerns about the control group. Am J Gastroenterol 2013;108:452-3.
37.
Molina-Infante J, Santolaria S, Fernandez-Bañares F, Montoro M, Esteve M.
Lymphocytic enteropathy, HLA DQ2/DQ8 genotype and wheat-dependent
symptoms: non-celiac wheat hypersensitivy or Marsh I celiac disease?. Am J
Gastroenterol 2013; 108:451.
38.
Molina Infante J, Martin Noguerol E, Alvarado Arenas M, Porcel Carreño SL,
Jimenez Timon S, Hernandez Arbeiza J. Reply. J Allergy Clin Immunol 2013;
131:613-4.
39.
Martin-Noguerol E, C. Martinez-Alcala, JM Gonzalez- Santiago, D. Vara- Brenes,
Molina-Infante J. Talidomida a dosis altas para la hemorragia digestiva oscura grave
en una paciente de alto riesgo trombótico. Gastroenterol Hepatol 2013;36:35-8.
40.
Molina-Infante J, Ferrando-Lamana L, Vinagre-Rodriguez G. Esophageal
hyperkeratosis after proton pump inhibitor therapy in a patient with esophageal
eosinophilia. Gastrointest Endosc 2013; 77:131-2.
41.
Molina Infante J, Martin Noguerol E, Alvarado Arenas M, Porcel Carreño SL,
Jiménez Timón S, Hernandez Arbeiza J. Selective elimination diet base don skin
testing has suboptimal efficacy for adult eosinophilic esophagitis. J Allergy
ClinImmunol 2012;130:1200-2.
42.
Molina-Infante J, Fernandez-Bermejo M, Mateos-Rodriguez JM. Recurrent
rectosigmoid volvulus and fatal peritonitis after percutaneous endoscopic
sigmoidostomy. Endoscopy 2012;44Suppl 2:E331-2.
Molina-Infante J, Dueñas-Sadornil C, Mateos Rodriguez JM, Perez-Gallardo B,
Vinagre-Rodriguez G, Hernandez-Alonso M, Fernandez-Bermejo M, GonzalezHuix F. Nonanesthesiologist-administered propofol vs. midazolam and propofol,
titrated to moderate sedation, for colonoscopy: a randomized controlled trial. Dig
Dis Sci 2012;57:2385-93.
44.
Molina-Infante J, Pazos-Pacheco C, Vinagre-Rodriguez G, Perez-Gallardo B,
Dueñas-Sadornil C, Hernandez-Alonso M, Gonzalez-Garcia G, Mateos Rodriguez
JM, Fernandez-Bermejo M, Gisbert JP. Non-bismuth quadruple (concomitant)
therapy: empiric and tailored efficacy vs. standard triple therapy for clarithromycinsusceptible Helicobacter pylori and vs. sequential therapy for clarithromycinresistant strains. Helicobacter 2012; 17:269-76.
45.
Gisbert JP, Castro-.Fernandez M, Perez-Aisa A, Cosme A, Molina-Infante J, et al.
Fourth-line rescue therapy with rifabutin in patients with three H. pylori eradication
failures. Aliment Pharmacol Ther 2012; 35:941-7.
46.
J. Molina Infante, E. Martin Noguerol, JM Gonzalez Santiago, C. Martinez Alcalá.
Esohageal Dieulafoy lesion resolved through endoscopic band ligation.
Gastroenterol Hepatol 2012;35:530-1
47.
J. Molina Infante, J. Zamorano. Distinguishing EoE from GERD upon PPIrefractoriness: what about PPI-responsive esophageal eosinophilia? Digestion 2012;
85:210.
48.
J.M. Gonzalez Santiago, J. Molina Infante, L. Crespo Rincón. Abdominal pain and
weight loss following adalimumab therapy. Gastroenterology 2012; 142;1489-90.
49.
J. Molina Infante, J.M Mateos Rodriguez, G Vinagre Rodriguez, E Martin
Noguerol, JM Gonzalez Santiago. Endoscopic-assisted colopexy and push
colostomy in the transverse colon for refractory chronic intestinal pseudoobstruction. Surg Laparosc Endosc Percutan Techn 2011; 21:e322-5.
50.
J. Molina Infante, M. Fernandez-Bermejo, J.M. Mateos-Rodriguez. Migrated
surgical clip-induced choledocholitiasis. Endoscopy 2011 Suppl2; E350-1.
51.
J. Molina Infante, G. Vinagre Rodriguez, E. Martin Noguerol. A rare cause of
dysphagia in an adult patient. Gastroenterology 2011; 141:1161-535.
52.
J. Molina Infante, M. Fernandez Bermejo, G. Vinagre Rodríguez. Severe gastric
ischemia after combined sclerotherapy in a bleeding peptic ulcer. Endoscopy 2011;
43Suppl 2:E191.
53.
J. Molina Infante, G. Vinagre Rodríguez, E. Martin Noguerol, JM González
Santiago, C. Martínez Alcalá. Coagulación con argón plasma para la mucosa
gástrica heterotópica cervical: una terapia eficaz para la disfagia no respondedora a
inhibidores de la bomba de protones. Gastroenterol Hepatol 2011;34:372-4.
J. Molina Infante, M. Hernández Alonso, G. Vinagre Rodríguez, E. Martín
Noguerol. Proton pump inhibitors therapy for esophageal eosinphilia: simply
following consensus guidelines. J Gastroenterol 2011; 46:712-3.
55.
J. Molina Infante, L. Ferrando-Lamana, C. Ripoll, et al. Esophageal eosinophilic
infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol
Hepatol 2011;9:110-7.
56.
J. Molina Infante, JP Gisbert. Levofloxacin in first-line eradication regimens for H
pylori: better test antibiotic susceptibility before treating. Gut 2011; 60:1605.
57.
J. Molina Infante, B. Perez Gallardo. Somatostatin analogues for bleeding
gastrointestinal angiodysplasias: when should thalidomide be prescribed?. Dig Dis
Sci 2011;56:266-7.
58.
J. Molina Infante, B. Pérez Gallardo, P. Barros Garcia. Successful pelvic abscess
drainage by cecal biopsies in Crohn´s disease. Gastrointest Endosc 2011;74:158-9.
59.
J. Molina Infante, J.M Mateos Rodríguez. Angiodisplasias. RevEspEnf 2010;
102:667.
60.
J. Molina Infante, G. Vinagre Rodriguez, E. Martin Noguerol, J.M Gonzalez
Santiago, C. Martínez Alcalá. Dieulafo y lesiono verthepectineal line. Gastroenterol
Hepatol 2010;756-7.
61.
J. Molina Infante, M. Fernandez Bermejo, B. Perez Gallardo. Removal of a
migrated covered metallic stent through an esophageal stricture with multiple
endoloops. Endoscopy 2010; Suppl2:E268-9.
62.
P. Barquilla-Cordero, M. Chiquero-Palomo, E. Martín-Noguerol, N. PachecoGomez, G. Vinagre-Rodriguez, S.L Moyano-Calvente, J Molina-Infante. Primary
pancreatic tuberculosis in an immunocompetent patient: first case report in Spain.
Gastroenterol Hepatol 2010;33:582-5.
63.
J. Molina Infante, J.P Gisbert..One size does not fit all – time to regionalize
Helicobacter Pylori eradication? authors reply. Aliment Pharmacol Ther
2010;32:507-8.
64.
J. Molina Infante, G. Vinagre Rodriguez, E. Martin Noguerol, J. M. Gonzalez
Santiago, M. Hernandez Alonso, B. Perez Gallardo, M. Fernandez Bermejo.
Duodenal erosions: an uncommon endoscopic marker of celiac disease. Rev Esp
Enferm Dig 2010;102:443-4.
65.
J. Molina Infante, J.P Gisbert. Clarithromycin or levofloxacin in the sequential
therapy for H. Pylori? authors reply. Aliment Pharmacol Ther 2010;31:1249-50.
J. Molina Infante, J. M. Mateos Rodriguez, M. Fernández Bermejo, B. Perez
Gallardo, M. Hernandez Alonso. Endoscopic trimming of an embedded distally
migrated metallic rectal stent with argon plasma coagulation. Surg Laparosc Endosc
Percutan Tech 2010;20:e73-5.
67.
J. Molina Infante, J. Zamorano. Acid suppressive therapy and eosinophilic
esophagitis: friends or foes? Am J Gastroenterol 2010; 105:699-700.
68.
J. Molina Infante, B. Perez-Gallardo, M. Fernandez-Bermejo, et al. Clinical trial:
clarithromycin vs. levofloxacin in first-line triple and sequential regimens for
Helicobacter pylori eradication. Aliment Pharmacol Ther 2010; 31:1077-84.
69.
J. Molina-Infante, L. Ferrando-Lamana. Eosinophilic esophagitis misdiagnosed
twice as esophageal candidiasis. Gastrointest Endosc 2010;71:395-6.
70.
J. Molina-Infante, L. Ferrando-Lamana. Novel endoscopic findings in gastric
giardiasis. Endoscopy 2009;41Suppl 2:E275.
71.
J. Molina-Infante, L. Ferrando-Lamana, Miguel Fernandez-Bermejo, S PorcelCarreño. Eosinophilic esophagitis in GERD patients: a clinicopathologic diagnosis
using proton pump inhibitors. Am J Gastroenterol 2009;104:2856-7.
72.
J. Molina Infante, B. Pérez Gallardo, M. Hernández Alonso, J.M. Mateos
Rodríguez, C. Dueñas Sadornil, M. Fernández Bermejo. Octreotide LAR for severe
obscure gastrointestinal haemorrhage in elderly patients with serious comorbidities.
Med Clin (Barc) 2009; 33(17):667-70.
73.
Cortes JR, Rivas MD, Molina-Infante J, Gonzalez-Nuñez MA, Perez-G M, Masa JF,
Sanchez JF, Zamorano J. Omeprazole inhibits IL-4 and IL-13 signaling signal
transducer and activator of transcription 6 activation and reduces lung inflammation
in murine asthma. J Allergy Clin Immunol 2009;124:607-10.
74.
J. Molina Infante, J. Bergua Burgués, N. Fernandez Gonzalez. Diarrhoea caused by
colonic relapse of follicular lymphoma. Brit JHaematol 2009;146:466.
75.
J. Molina Infante, M. Fernández Bermejo, L. Ferrando Lamana, M.S. Jiménez
Timón. Esofagitis eosinofilica respondedora a IBP con pHmetría normal. Revista de
la ACAD vol XXV (65-66); 2009.
76.
J. Molina Infante, M. Hernandez Alonso, B. Pérez Gallardo, E. Martin Noguerol.
Megacolon y megarecto idiopático. Rev Esp Enf Dig 2009;101:352-4.
77.
Gisbert JP, Bermejo MF, Infante JM, Gallardo BP, Bermejo AB, Rodríguez JM,
Andrés PR, García GG. Levofloxacin, Amoxicillin, and Omeprazole as First-line
Triple Therapy for Helicobacter pylori Eradication. J Clin Gastroenterol 2009;
43:384-5.
J. Molina Infante, M. Fernandez Bermejo, E. Martin Noguerol, B. Pérez Gallardo.
Hidatidosis biliar. Rev Esp Enf Dig 2009; 101:136-8.
79.
J. Molina Infante, M. Hernandez Alonso, B. Pérez Gallardo, E. Martin Noguerol.
The first Asian case report of eosinophilic esophagitis in an asymptomatic adult:
what about a proton pump inhibitor trial?. J Chin MedAssoc 2009; 72:166-7.
80.
J. Molina Infante, M. Hernández Alonso, E. Martín Noguerol, B. Pérez Gallardo, C.
Dueñas Sadornil. Alopecia areata como presentación inicial paraneoplásica de un
cáncer gástrico. Gastroenterol Hepatol 2009; 32:128-30.
81.
J. Molina Infante, L. Ferrando Lamana, JM Mateos Rodriguez, B. Perez Gallardo,
AB Prieto Bermejo. Overlap of reflux and eosinophilic esophagitis in two patients
requiring different therapies: review of the litarature. World J Gastroenterol 2008;
14:1463-6.
82.
J. Molina Infante, M. Hernández Alonso, J.M Mateos Rodriguez, C. Dueñas
Sadornil, G. Gonzalez García, M. Fernández Bermejo, et al. Ectasia vascular antral
gástrica refractaria con extensión al estómago proximal. Rev Esp Enf Dig 2009;
101:75-6.
83.
J. Molina Infante, A.B. Prieto Bermejo, B. Pérez Gallardo, M. Fernández Bermejo.
Pancreatitis aguda tóxica por metformina sin insuficiencia renal. MedClin (Barc)
2008; 131:519.
84.
J. Molina Infante, M. Hernández Alonso. Hepatobiliary and pancreatic: malignant
gallbladder polyp. J Gastroenterol Hepatol 2008;23:1622.
85.
Coll-Fernández R, Coll R, Pascual T, Sánchez Muñoz-Torrero JF, Sahuquillo JC,
Manzano L, Aguilar E, Alcala-Pedrajas JN, Alvarez LR, García-Díaz AM,
MujalA,Yeste M, Monreal M. Cardiacrehabilitation and outcome in stable out
patients with recent myocardial infarction. Arch Phys Med Rehabil. 2014
Feb;95(2):322-9. doi:10.1016/j.apmr.2013.09.020. Epub 2013 Oct 9. PubMed
PMID: 24121084.
86.
Di Micco P, Ruiz-Giménez N, Nieto JA, Aujesky D, del Molino F, Valle R, Barrón
M, Maestre A, Monreal M; RIETE investigators. Platelet count and outcome in
patients with acute venous thromboembolism. ThrombHaemost. 2013
Nov;110(5):1025-34. doi: 10.1160/TH13-04-0352. Epub 2013 Aug 8. PubMed
PMID: 23925476.
87.
Bertoletti L, Quenet S, Laporte S, Sahuquillo JC, Conget F, Pedrajas JM, Martin M,
Casado I, Riera-Mestre A, Monreal M; RIETE Investigators. Pulmonary embolism
and 3-month outcomes in 4036 patients with venous thromboembolism and chronic
obstructive pulmonary disease: data from the RIETE registry. Respir Res. 2013 Jul
18;14:75. doi: 10.1186/1465-9921-14-75. PubMed PMID: 23865769; PubMed
Central PMCID: PMC3728047.
Nieto JA, Solano R, Trapero Iglesias N, Ruiz-Giménez N, Fernández-Capitán C,
Valero B, Tiberio G, Bura-Riviere A, Monreal M; RIETE Investigators. Validation
of a score for predicting fatal bleeding in patients receiving anticoagulation for
venous
thromboembolism.
Thromb
Res.
2013
Aug;132(2):175-9.
doi:10.1016/j.thromres.2013.06.019. Epub 2013 Jul 9. PubMed PMID: 23849097.
89.
Merino J, Mateo-Gallego R, Plana N, Bea AM, Ascaso J, Lahoz C, Aranda JL;
Hypertriglyceridemic Registry of Spanish Arteriosclerosis Society. Low-fat dairy
products consumption is associated with lower triglyceride concentrations in a
Spanish hypertriglyceridemic cohort. NutrHosp. 2013 May-Jun;28(3):927-33. doi:
10.3305/nh.2013.28.3.6363. PubMed PMID: 23848121.
90.
Lecumberri R, Alfonso A, Jiménez D, Fernández Capitán C, Prandoni P, Wells PS,
Vidal G, Barillari G, Monreal M; RIETE investigators. Dynamics of case-fatalilty
rates of recurrent thromboembolism and major bleeding in patients treated for
venous thromboembolism. ThrombHaemost. 2013 Oct;110(4):834-43. doi:
10.1160/TH13-02-0132. Epub 2013 Jul 11. PubMed PMID: 23846721.
91.
Bernaudo D, Coll R, Sánchez Muñoz-Torrero JF, Pascual MT, García-Díaz AM,
Alvarez LR, Monreal M; FRENA Investigators. Renal function and short-term
outcome in stable outpatients with coronary, cerebrovascular or peripheral artery
disease.
Atherosclerosis.
2013
Jul;
229(1):258-62.
doi:10.1016/j.atherosclerosis.2013.04.029. Epub 2013 May 9. PubMed PMID:
23714334.
92.
Pedragosa A, Merino J, Aranda JL, Galiana J, Godoy D, Panisello JM, Ascaso JF,
Civeira F, Masana L, Pedro-Botet J; Registro de HTG de la SEA. Perfil clínico de
los pacientes con hipertrigliceridemia muy severa del Registro de
Hipertrigliceridemias de la Sociedad Espanola de Arteriosclerosis.
ClinInvestigArterioscler.
2013
Jan-Mar;
25(1):8-15.
doi:
10.1016/j.arteri.2012.11.001. Epub 2012 Dec 21. Spanish. PubMed PMID:
23522276.
93.
Trujillo-Santos J, Schellong S, Falga C, Zorrilla V, Gallego P, Barrón M, Monreal
M; RIETE Investigators. Low-molecular-weight or unfractionated heparin in venous
thromboembolism: the influence of renal function. Am J Med. 2013
May;126(5):425-434.e1. doi: 10.1016/j.amjmed.2012.09.021. Epub 2013 Mar 14.
PubMed PMID: 23499331.
94.
Otero R, Elías T, Jara L, Trujillo-Santos J, Bertoletti L, Nauffal D, Ruiz-Ruiz J,
Blanco-Molina Á, Monreal M; RIETE investigators. Factors associated with
elevated pulmonary arterial pressure levels on the echocardiographic assessment in
patients with prior pulmonary embolism. Thromb Res. 2013 May;131(5):e191-5.
doi: 10.1016/j.thromres.2013.01.034. Epub 2013 Mar 7. PubMed PMID: 23466216.
Sanclemente C, Yeste M, Suarez C, Coll R, Aguilar E, Sahuquillo JC, Lerma R,
Monreal M; FRENA investigators. Predictors of outcome in stable outpatients with
peripheral artery disease. Intern Emerg Med. 2014 Feb;9(1):69-77. doi:
10.1007/s11739-012-0854-1. Epub 2012 Sep 29. PubMed PMID: 23054402.
96.
Soler S, Delgado C, Ballaz A, Cisneros E, Malý R, Babalis D, Monréal M; RIETE
Investigators. Unsuspected pulmonary embolism in patients with cancer. Thromb
Res. 2012 Apr;129 Suppl 1:S16-9. doi: 10.1016/S0049-3848(12)70010-5. PubMed
PMID: 22682127.
97.
den Exter PL, Gómez V, Jiménez D, Trujillo-Santos J, Muriel A, Huisman MV,
Monreal M; Registro Informatizado de la Enfermedad TromboEmbólica (RIETE)
Investigators. A clinical prognostic model for the identification of low-risk patients
with acute symptomatic pulmonary embolism and active cancer. Chest. 2013
Jan;143(1):138-45. PubMed PMID: 22814859.
98.
Nauffal D, Ballester M, Reyes RL, Jiménez D, Otero R, Quintavalla R, Monreal M;
RIETE Investigators. Influence of recent immobilization and recent surgery on
mortality in patients with pulmonary embolism. J ThrombHaemost. 2012 Sep;
10(9):1752-60. doi: 10.1111/j.1538-7836.2012.04829.x. PubMed PMID: 22726525.
99.
Aguilar E, García-Díaz AM, Sánchez Muñoz-Torrero JF, Alvarez LR, Piedecausa
M, Arnedo G, Monreal M; FRENA Investigators. Clinical outcome of stable
outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial
fibrillation. Thromb Res. 2012 Sep; 130(3):390-5. Epub 2012 May 31. PubMed
PMID: 22658293.
100.
Riera-Mestre A, Jiménez D, Muriel A, Lobo JL, Moores L, Yusen RD, Casado I,
Nauffal D, Oribe M, Monreal M; RIETE investigators. Thrombolytic therapy and
outcome of patients with an acute symptomatic pulmonary embolism. J
ThrombHaemost. 2012 May; 10(5):751-9. doi: 10.1111/j.1538-7836.2012.04698.x.
101.
Nuñez MJ, Villalba JC, Cebrián E, Visoná A, Lopez-Jimenez L, Núñez M, Szwebel
TA, Luque JM, Jaras MJ, Monreal M; RIETE Investigators. Venous
thromboembolism in immobilized patients with dementia. Findings from the RIETE
registry. Thromb Res. 2012 Aug;130(2):173-7. Epub 2012 Feb 27. PubMed PMID:
22374336.
102.
Di Micco P, Fontanella A, Falvo N, Bonithon-Kopp C, Decousus H, Riera-Mestre
A, Monreal M; RIETE Investigators. Natural history of patients developing
thrombocytopenia while receiving anticoagulant therapy for venous
thromboembolism. IntAngiol. 2012 Feb; 31(1):92-5. PubMed PMID: 22330631.
Gabriel F, Portolés O, Labiós M, Rodríguez C, Cisneros E, Vela J, Nuñez M;
RIETE Investigators. Usefulness of thrombophilia testing in venous
thromboembolic
disease:
findings
from
the
RIETE
registry.
ClinApplThrombHemost.
2013
Jan-Feb;19(1):42-7.
doi:
10.1177/1076029611436193. Epub 2012 Feb 12. PubMed PMID: 22327823.
104.
Tzoran I, Saharov G, Brenner B, Delsart D, Román P, Visoná A, Jiménez D,
Monreal M; RIETE Investigators. Silent pulmonary embolism in patients with
proximal deep vein thrombosis in the lower limbs. J ThrombHaemost. 2012 Apr;
10(4):564-71. doi: 10.1111/j.1538-7836.2012.04648.x. PubMed PMID: 22288520.
105.
Marchena PJ, Nieto JA, Guil M, García-Bragado F, Rabuñal R, Boccalon H,
Trujillo-Santos J, Monreal M; RIETE Investigators. Long-term therapy with lowmolecular-weight heparin in cancer patients with venous thromboembolism.
ThrombHaemost. 2012 Jan;107(1):37-43. doi: 10.1160/TH11-06-0423. Epub 2011
Nov 24. Erratum in: ThrombHaemost. 2012 Apr; 107(4):801. Multiple investigator
names added. PubMed PMID: 22116496.
106.
Alvarez LR, Balibrea JM, Suriñach JM, Coll R, Pascual MT, Toril J, López-Jiménez
L, Monreal M; FRENA Investigators. Smoking cessation and outcome in stable
outpatients with coronary, cerebrovascular, or peripheral artery disease. Eur J Prev
Cardiol. 2013 Jun;20(3):486-95. doi: 10.1177/1741826711426090. Epub 2011 Oct
3. PubMed PMID: 21968571.
107.
Muñoz-Torrero JF, Bounameaux H, Pedrajas JM, Lorenzo A, Rubio S,
KearonC,Hernández L, Monreal M; Registro Informatizado de la Enfermedad
TromboEmbólica(RIETE) Investigators. Effects of age on the risk of dying from
pulmonaryembolism or bleeding during treatment of deep vein thrombosis. J Vasc
Surg. 2011 Dec; 54(6 Suppl):26S-32S. doi: 10.1016/j.jvs.2011.05.114. Epub 2011
Sep 9. PubMed PMID: 21908150.
108.
Lobo JL, Nieto JA, Zorrilla V, Garrido N, Madridano O, Ruiz J, Farge-Bancel D,
Tiberio G, Uresandi F, Monreal M; RIETE Investigators. Venous thromboembolism
in patients with intracranial haemorrhage. ThrombHaemost. 2011 Oct;106(4):750-2.
doi: 10.1160/TH11-02-0136. Epub 2011 Sep 8. Erratum in: Thromb Haemost. 2011
Dec;106(6):1234. Timiraos, J [added]. PubMed PMID: 21901229.
109.
Vega J, Romaní S, Garcipérez FJ, Vicente L, Pacheco N, Zamorano J, GómezBarrado JJ, Sánchez Muñoz-Torrero JF. Peripheral arterial disease: efficacy of the
oscillometric method. Rev EspCardiol (Engl Ed). 2011 Jul;64(7):619-21.doi:
10.1016/j.rec.2010.12.006. Epub 2011 Mar 23. PubMed PMID: 24775652.
Vega J, Romaní S, Garcipérez FJ, Vicente L, Pacheco N, Zamorano J,GómezBarrado JJ, Sánchez Muñoz-Torrero JF. [Peripheral arterial disease:efficacy of the
oscillometric method]. Rev EspCardiol. 2011 Jul; 64(7):619-21.doi:
10.1016/j.recesp.2010.10.019. Epub 2011 Mar 23. Spanish. PubMed
PMID:21435772.
111.
Ascaso JF, Millán J, Mateo-Gallego R, Ruiz A, Suarez-Tembra M, Borrallo RM,
Zambon
D,
Gonzalez-Santos
P,
Peres-de-Juan
M,
Ros
E;
HypertriglyceridemiaRegistry of Spanish Arteriosclerosis Society. Prevalence of
metabolic syndrome and cardiovascular disease in a hypertriglyceridemic
population.
Eur
J
Intern
Med.
2011
Apr;
22(2):177-81.
doi:
10.1016/j.ejim.2010.12.011. Epub 2011 Jan 14. PubMed PMID: 21402249.
112.
Trujillo-Santos J, Casas JM, Casado I, Samperiz AL, Quintavalla R, Sahuquillo JC,
Monreal M; RIETE Investigators. Thirty-day mortality rate in women with cancer
and venous thromboembolism. Findings from the RIETE Registry. Thromb Res.
2011 Feb;127Suppl 3:S1-4. doi: 10.1016/S0049-3848(11)00006-5. Erratum in:
Thromb Res. 2011 Aug;128(2):e1. Casa, José Manuel [corrected to Casas, José
Manuel]. PubMed PMID: 21262424.
113.
Sanchez Muñoz-Torrero JF, Rivas MD, Costo A, Crespo L, Fraile J, Doncel
C,Fernandez Toro JM, Zamorano J. Telmisartan improves insulin resistance in
patients with low cytokine levels. J InvestigMed. 2011 Mar; 59(3):602-5.
doi:10.231/JIM.0b013e31820bf26b. PubMed PMID: 21245772.
114.
Bertoletti L, Righini M, Bounameaux H, López-Jiménez L, Tiraferri E, Visona A,
Monreal M; RIETE Investigators. Acute venous thromboembolism after non-major
orthopaedic surgery or post-traumatic limb immobilisation. Findings from the
RIETE registry. ThrombHaemost. 2011 Apr;105(4):739-41. doi: 10.1160/TH10-110751. Epub 2011 Jan 12. PubMed PMID: 21225101.
115.
Muñoz-Torrero JF, Escudero D, Suárez C, Sanclemente C, Pascual MT, ZamoranoJ,
Trujillo-Santos J, Monreal M; Factores de Riesgo y ENfermedad Arterial
(FRENA)Investigators. Concomitant use of proton pump inhibitors and clopidogrel
in patients with coronary, cerebrovascular, or peripheral artery disease in the
factores de Riesgo y Enfermedad Arterial (FRENA) registry. J Cardiovasc
Pharmacol. 2011 Jan;57(1):13-9. doi: 10.1097/FJC.0b013e3181fc65e5. PubMed
PMID:21164357.
116.
Sánchez Muñoz-Torrero JF, Crespo L, Fernández Pereira L, Pereira G,
CámaraC,Costo A. [Atorvastatin and oxidized low density lipoprotein antibody.
Relationship to age]. Med Clin (Barc). 2011 Feb 26;136(5):199-201.
doi:10.1016/j.medcli.2010.05.028. Epub 2010 Dec 8. Spanish. PubMed PMID:
21145076.
Soto MJ, Grau E, Gadelha T, Palareti G, Bounameaux H, Villalta J, Monreal M;
RIETE Investigators. Clinical significance of a negative D-dimer level in patients
with confirmed venous thromboembolism. Findings from the RIETE Registry. J
Thromb Haemost. 2011 Feb;9(2):407-10. doi: 10.1111/j.1538-7836.2010.04143.x.
118.
Mozo, L., D. Rivas, J. Zamorano, and C. Gutiérrez. 1993. Differential expression of
IL-4 receptors in human T and B lymphocytes. J. Immunol. 1993; 150:4261-4269.
119.
Zamorano, J., D. Rivas, A. Gayo, L. Mozo, and C. Gutiérrez. 1995. Soluble but not
immobilized anti-IgM antibody inhibits post-activation events leading to T celldependent B cell differentiation. Immunology. 1995; 85:241-247.
120.
Rivas, D., L. Mozo, J. Zamorano, A. Gayo, J.C. Torre, A. Rodríguez, and C.
Gutiérrez. 1995. Upregulated expression of IL-4 receptor and increased levels of IL4 in rheumatoid arthritis patients. J. Autoimmun. 8:587-600.
121.
Suárez, A., L. Mozo, A. Gayo, J. Zamorano, and C. Gutiérrez. 1997. Requirement of
a second signal via protein kinase C or protein kinase A for a maximal expression of
CD40 ligand. Involvement of transcriptional and postranscriptional mechanisms.
Eur. J. Immunol. 1997; 27:2822-2829.
122.
Zamorano, J., H.Y. Wang, L.-M. Wang, J.H. Pierce, and A.D. Keegan. 1996. IL-4
protects cells from apoptosis via the insulin receptor substrate pathway and a second
independent signaling pathway. J. Immunol. 1996; 157:4926-4934.
123.
Wang, H.Y., J. Zamorano, J. Yoerkie, W.E. Paul, and A.D. Keegan. 1997. IL-4induced tyrosine phosphorylation of IRS-1 is dependent upon expression of JAK-1
in human fibrosarcoma cells. J. Immunol. 1997; 158:1037-1040.
124.
Wang, D.Z., J. Zamorano, A.D. Keegan, and M.R. Boothby. 1997.HMG-I(Y)
phosphorylation status as a nuclear target regulated through the I4R motif of the
Interleukin-4 receptor. J. Biol. Chem. 1997; 272:25083-25090.
125.
Zamorano, J., H.Y. Wang, R.X. Wang, Y. Shi, G.D. Longmore, and A.D. Keegan.
1998. Regulation of cell growth by IL-2: role of STAT5 in protection from
apoptosis but not in cell cycle progression. J. Immunol. 1998; 160:3502-3512.
126.
Keegan A.D. and J. Zamorano. 1998. Regulation of gene expression, growth, and
cell survival by IL-4: Contribution of multiple signaling pathways. Cell Res. 1998;
8:1-13.
127.
Wang, H.Y., J. Zamorano, and A.D. Keegan. 1998. A role for the InsulinInterleukin (IL)-4 receptor motif of the IL-4Ra in regulating activation of the insulin
receptor substrate 2 and signal transducer and activator of transcription-6 pathways.
Analysis by mutagenesis. J. Biol. Chem. 1998; 273:9898-9905.
Zamorano, J., and A.D. Keegan. 1998. Regulation of apoptosis by tyrosinecontaining domains of the IL-4Ra: Y497 and Y713, but not the STAT6-docking
tyrosines, signal protection from apoptosis. J. Immunol. 1998; 161:859-867.
129.
Mozo L, A. Gayo, A. Suarez, D. Rivas, J. Zamorano, and C
Gutierrez.1998.Glucocorticoids inhibit IL-4 and mitogen-induced IL-4Ra chain
expression by different post-transcriptional mechanisms. J. Allergy Clin Immunol.
1999; 102:968-76.
130.
Wang H.Y., C.P. Shelburne, J. Zamorano, A.E. Kelly, and A.D. Keegan. 1999.
Effects of an allergy-associated mutation in the huIL-4Ra (Q576R) on huIL-4induced signal transduction. J. Immunol. 1999; 162:4385-4389.
131.
Nelms, K., J.J. Ryan, J. Zamorano, A.D. Keegan, and W.E. Paul. 1999. The IL-4
receptor: signaling mechanims and biological functions. Annu. Rev. Immunol.
1999; 17:701-738.
132.
Zamorano, J., A.E. Kelly, J. Austrian, H.Y. Wang, and A.D. Keegan. 2001.
Costimulation of resting B lymphocytes alters the IL-4-activated IRS-2 pathway in a
STAT6 independent manner: implications for survival and proliferation. Cell Res.
2001; 11:44-54.
133.
Zamorano, J., A. L. Mora, M. Boothby, and A.D. Keegan. 2001. NF-kB activation
plays an important role in the IL-4-induced protection from apoptosis. Int Immunol.
2001; 13:1479-1487.
134.
Perez-G M., M. Melo, A.D. Keegan, and J. Zamorano. 2002. Aspirin and salicylates
inhibit the IL-4- and IL-13-induced activation of STAT6. J. Immunol. 2002;
168:1428-1434.
135.
J. Zamorano, M.D. Rivas, and M. Perez-G. 2003. Interleukin-4: A multifunctional
cytokine. Inmunología 2003; 22:215-224.
136.
Zamorano, J., M.D. Rivas, A. Garcia-Trinidad, C.K. Qu, and A.D. Keegan. 2003.
Phosphatidylcholine-specific phospholipase C activity is necessary for the activation
of STAT6. J. Immunol. 2003; 171:4203-4209.
137.
Zamorano J., M.D. Rivas, F. Setien, and M. Perez-G. 2005. Proteolytic regulation of
activated STAT6 by calpains. J. Immunol. 2005; 174:2843-2848.
138.
Sanchez de Cos, J., D. Masjoans, M.A. Sojo, J. Zamorano, C. Disdier, and M. C.
Perez. 2007. Metástasis encefálicas silentes en la estadificación inicial del cáncer de
pulmón. Evaluación mediante tomografía computarizada y resonancia magnética.
Arch Bronconeumol. 2007; 43:386-391.
Cortes J.R., M. Perez-G, M.D. Rivas, and J. Zamorano. 2007. Kaempferol inhibits
IL-4-induced STAT6 activation by specifically targeting JAK3. J Immunol. 2007;
179:3881-3887. IF 6.0 Q1
140.
Perez-G, M., J.R. Cortes, M.D. Rivas, F. Masa, and J. Zamorano. 2008. Treatment
of cells with n-alpha-tosyl-L-phenylalanine-chloromethyl ketone induces the
proteolytic loss of STAT6 transcription factor. Mol Immunol. 2008; 45:3896-3901.
IF 3.5 Q2
141.
Masa J.F., J. Corral., J. Teran,.M.J. Martin, C. Disdier, M. Rubio, M. Mota, J.
Zamorano, and J.M. Montserrat. 2009. Apnoeic and obstructive non-apnoeic sleep
respiratory events. Eur Respir J. 2009; 34:156-161. IF 5.9 D1
142.
Cortes, J.R., M.D. Rivas, J. Molina-Infante, M.A. Gonzalez-Nuñez, M. erez-G, J.F.
Masa, J.F. Sanchez, and J. Zamorano. 2009. Omeprazole inhibits IL-4 and IL-13
signaling STAT6 activation and reduces lung inflammation in murine asthma. J
Allergy Clin Immunol. 2009; 124:607-610, 610e1. IF 9.5 D1
143.
Molina-Infante, J., and J. Zamorano. 2010.Acid-Suppressive Therapy and
Eosinophilic Esophagitis: Friends or Foes ?Am J Gastroenterol 2010; 105:699-700.
IF 6.8 D1
144.
Vega, J., S. Romani, F.J. Garciperez, J. Zamorano, and J.F. Sanchez. 2010.
145.
Ankle-brachial index measurement in primary care setting. South Med. J. 2010;
103:590. IF 0.76 Q3
146.
J.F. Sanchez, P. Barquilla, R. Velasco, C. Fernandez, N. Pacheco, L. Vicente, J.L.
Chicon, S. Trejo. J. Zamorano, and A. Lorenzo. 2010. Adverse drug reactions in
internal medicine units, and risk factors associated.Eur. J. Clin. Pharmacol. 2010;
66:1257-1264. IF 3.03 Q2
147.
Sanchez Muñoz-torrero, J.F., L. Crespo, J.M. Ramirez, F. Álvarez, J. Luengo, J.
Mateos, N.R. Robles, J. Zamorano, and A. Costo. 2010.Efectos de un consejo
nutricional simple en pacientes de alto riesgo vascular. Clin Invest Arterioscl. 2011;
23(1):8-14.
148.
Masa, J.F., M.T. Gonzalez, R. Pereira, M. Mota, J.A. Riesco, J. Corral, J. Zamorano,
M. Rubio, J. Teran, and R. Farre. 2010. Validity of spirometry performed onlineEur. Respir. J. 2011; 37:911-918. IF 5.9 D1
Sanchez Muñoz-Torrero, J.F., D. Escudero, C. Suarez, C. Sanclemente, M.T.
Pascual, J. Zamorano, M. Monreal and the FRENA Investigators. 2011.
Concomitant use of proton-pump inhibitors and clopidogrel in patients with
coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA
Registry. J Cardiovasc Pharm 2011; 57:13-19. IF 2.4 Q2
150.
Sanchez Muñoz-Torrero, J.F., M.D. Rivas, A. Costo, L. Crespo, J. Fraile, C. Doncel,
J.M. Fernandez-Toro, and J. Zamorano. 2011. Telmisartan improves insulin
resistance in patients with low cytokine levels.J. Invest. Med. 2011; 59:602-605. IF
1.54 Q2
151.
Vega J., S. Romani, F.J. Garciperez, L. Vicente, N. Pacheco, J. Zamorano, J.J.
Gomez-Barrado, and J.F. Sanchez. 2011. Peripheral arterial disease: Efficacy of the
oscillometric method. Rev Esp Cardiol. 2011; 64:619-621. IF 2.16 Q2
152.
Masa JF, Corral J, Pereira R, Duran-Cantolla J, Cabello M, Hernández-Blasco L,
Monasterio C, Alonso A, Chiner E, Zamorano J, Aizpuru F, Montserrat JM;
SpanishSleep Network. 2011. Therapeutic decision-making for sleep apnea and
hypopnea syndrome using home respiratory polygraphy: a large multicentricstudy.
Am J RespCrit Care Med. 2011; 184(8):964-71. IF 10.19 D1
153.
Muñoz-Torrero JF, Zamorano J. 2011.Vertebral fractures. N Engl J Med. 2011;
365(7):673-4. IF 53.5 D1
154.
Molina-Infante, J, J. Zamorano, M.D. Rivas, and M. Fernandez-Bermejo.
2011.Proton pump inhibitors therapy for eosinophilic esophagitis. J Aller Ther
2011; S8(002):1-4.
155.
Molina-Infante, J, and J. Zamorano. 2012. Distinguishing eosinophilic esophagitis
from gastroesophageal reflux disease upon PPI refractoriness: What about PPIresponsive esophageal eosinophilia?.Digestion 2012; 85:210. IF 2.15 Q3
156.
Sanchez Muñoz-Torrero, J.F., M.D. Rivas, R. Alonso, L. Crespo, A. Costo, M.
Roman, C. Martin, and J. Zamorano. 2012.Influence of lipoprotein (a) on
inflammatory biomarkers in metabolic syndrome. South Med. J. 2012; 105:339-343.
IF 0.76 Q3.
157.
Masa J. F., J.Corral, J. Gomez de Terreros, J. Duran-Cantolla, M. Cabello, L.
Hernández-Blasco, C. Monasterio, A. Alonso, E. Chiner, F. Aizpuru, J. Zamorano,
R. Cano, J.M. Montserrat; Collaborating group, Garcia-Ledesma E, Pereira R,
Cancelo L, Martinez A, Sacristan L, Salord N, Carrera M, Sancho-Chust JN, Embid
C. 2013.Significance of including a surrogate arousal for sleep apnea-hypopnea
syndrome diagnosis by respiratory polygraphy. Sleep. 2013 Feb 1; 36(2):249-57.
doi: 10.5665/sleep.2384. PMID: 23372273
Cabrera C. M. , J. M. Urra, A. Carreño A, and J. Zamorano. 2013Differential
expression of CD30 on CD3 T-lymphocytes in patients with systemic lupus
erythematosus.Scand J Immunol. 2013 Sep; 78(3):306-12. doi: 10.1111/sji.12088.
PMID 23790231.
159.
Molina-Infante, J., MD Rivas, G Vinagre, M Hernandez, JM Mateos, C Dueñas, B
Perez, R Bañares, J Zamorano. Remission in Proton pump inhibitor-responsive
oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2
cytokines overexpression. Gastroenterology 2013; 144 (Suppl 1): S-484.
160.
Masa JF, Corral J, Sanchez de Cos J, Duran-Cantolla J, Cabello M, HernándezBlasco L, Monasterio C, Alonso A, Chiner E, Aizpuru F, Vázquez-Polo FJ,
Zamorano J, Montserrat JM; Collaboratinggroup:, Garcia-Ledesma E, Pereira R,
Cancelo L, Martinez A, Sacristan L, Salord N, Carrera M, Sancho-Chust JN, Negrín
MA, Embid C. Effectiveness of threesleep apnea management alternatives. Sleep.
2013 Dec 1; 36(12):1799-807. doi: 10.5665/sleep.3204. PMID: 24293754
161.
Urra, J. M.,Feo Brito, F., Carrasco, P., De la Roca, F., Zamorano, J.Allergen
stimulation induces simultaneous production of type 2 helper T cells and regulatory
cytokines in patients with pollen allergy. J Investig Allergol Clin Immunol, 2013;
23:54-55. PMID: 23653976
162.
Molina-Infante, J., Rivas, M. D., Hernandez-Alonso, M., Vinagre-Rodriguez, G.,
Mateos-Rodriguez, J. M., Duenas-Sadornil, C., Perez-Gallardo, B., FerrandoLamana, L., Fernandez-Gonzalez, N., Banares, R., Zamorano, J. Proton pump
inhibitor responsive oesophageal eosinophilia correlates with down regulation of
eotaxin-3 and Th2 cytokinesoverexpression. Aliment Pharmacol Ther. 2014,
doi:10.1111/apt.12914. PMID: 25112708
163.
Sanchez Munoz-Torrero J. F., Lorenzo-Hernandez A., Trujillo-Santos J., FernandezCapitan C., Zamorano J.,MonrealM.Natural history of venous thromboembolism in
patients from the Mediterranean region. A systematic reviewRevClin Esp. 2014;
184-191. PMID 24564993
164.
Sanchez Munoz-Torrero J. F., Rivas M. D., Zamorano J., Alonso R., Joya-Vazquez
P., Padro T., Mata P.rs1801275 Interleukin-4 receptor alphapolymorphism in
familial hypercholesterolemia. J Clin Lipidol. 2014; 8:418-422. PMID: 25110223.
165.
Molina-Infante J, Rodriguez-Sanchez J, Martinek J, van Rhijn BD, Krajciova J,
Rivas MD, Barrio J, Moawad FJ, Martinez-Alcalá C, Bredenoord AJ, Zamorano J,
Dellon ES. Long-Term Loss of Response in Proton Pump Inhibitor-Responsive
Esophageal Eosinophilia Is Uncommon and Influenced by CYP2C19 Genotype and
Rhinoconjunctivitis. Am J Gastroenterol. 2015 Nov;110(11):1567-75. doi:
10.1038/ajg.2015.314. Epub 2015 Sep 29. PMID: 26416193.
Concierto Complejo Hospitalario de Cáceres – Universidad de Extremadura 17

PUBLICACIONES GEEIC - Área de Salud de Cáceres

Transcripción

Documentos relacionados

Nell`ambito dell` iniziativa Loving Spring Gravedona

- EPJ Web of Conferences

INSUMOS FARMACEUTICOS

design Lievore, Altherr, Molina, 2005